These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1815141)

  • 21. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
    Di Matteo V; Pierucci M; Esposito E
    J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study.
    Feigenbaum JJ; Howard SG
    Life Sci; 1997; 60(19):1659-68. PubMed ID: 9129121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of L-dopa on in vitro dopamine release from striatum.
    Snyder GL; Zigmond MJ
    Brain Res; 1990 Feb; 508(2):181-7. PubMed ID: 2106362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of synaptosomal dopamine synthesis by corticotropin-releasing factor in rat striatum: role of Ca2+-dependent mechanisms.
    Olianas MC; Onali P
    Eur J Pharmacol; 1989 Jul; 166(2):165-74. PubMed ID: 2477258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
    Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effect of prolactin on dopamine release from the rat dorsal and ventral striatum and from the mediobasal hypothalamus superfused in vitro.
    Chen JC; Ramirez VD
    Eur J Pharmacol; 1988 Apr; 149(1-2):1-8. PubMed ID: 2456219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes.
    Shu C; Selmanoff M
    Endocrinology; 1988 Jun; 122(6):2699-709. PubMed ID: 3131121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M; Mizobe F; Yamamoto T; Kato T
    Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Intermittent Hypoxia on Brain Dopamine in Amphetaminized Rats.
    Yu PL; Cheng SY; Chou JC; Pan WH; Wang SW; Wang PS
    Chin J Physiol; 2015 Aug; 58(4):219-27. PubMed ID: 26211645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thyrotropin-releasing hormone (TRH): action mechanism of an enhanced dopamine release from rat striatal slices (author's transl)].
    Narumi S; Nagai Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):239-50. PubMed ID: 119692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of taurine on 4-aminopyridine-stimulated release of labelled dopamine from striatal synaptosomes.
    Arzate ME; Morán J; Pasantes-Morales H
    Neuropharmacology; 1986 Jul; 25(7):689-94. PubMed ID: 3018620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
    Demarest KT; Riegle GD; Moore KE
    Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study.
    Harsing LG; Sershen H; Toth E; Hashim A; Ramacci MT; Lajtha A
    Eur J Pharmacol; 1992 Jul; 218(1):117-21. PubMed ID: 1397026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of striatal interneurons in age-related effects upon potassium- and amphetamine-stimulated dopamine release.
    Dluzen DE; Laping NJ; Ramirez VD
    Brain Res; 1988 Apr; 445(2):354-7. PubMed ID: 3370468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.